The DOI matches its Crossref record; 228 of the 228 references it cites were found in a registry or an index.
The Classification of Microglial Activation Phenotypes on Neurodegeneration and Regeneration in Alzheimer’s Disease Brain
Open accessAbstract
Alzheimer's disease (AD) is a neurodegenerative disease characterized by progressive decline of cognitive function. There is no therapy that can halt or reverse its progression. Contemporary research suggests that age-dependent neuroinflammatory changes may play a significant role in the decreased neurogenesis and cognitive impairments in AD. The innate immune response is characterized by pro-inflammatory (M1) activation of macrophages and subsequent production of specific cytokines, chemokines, and reactive intermediates, followed by resolution and alternative activation for anti-inflammatory signaling (M2a) and wound healing (M2c). We propose that microglial activation phenotypes are analogous to those of macrophages and that their activation plays a significant role in regulating neurogenesis in the brain. Microglia undergo a switch from an M2- to an M1-skewed activation phenotype during aging. This review will assess the neuroimmunological studies that led to characterization of the different microglial activation states in AD mouse models. It will also discuss the roles of microglial activation on neurogenesis in AD and propose anti-inflammatory molecules as exciting therapeutic targets for research. Molecules such as interleukin-4 and CD200 have proven to be important anti-inflammatory mediators in the regulation of neuroinflammation in the brain, which will be discussed in detail for their therapeutic potential.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Polazzi, E., Mengoni, I., Caprini, M., Peña-Altamira, E., Kurtys, E., & Monti, B. (2013) · Neurosignals · doi:10.1159/000337115 · Cited by 8,994
Glutamate neurotoxicity and diseases of the nervous system
CHOI, D. (1988) · Neuron · doi:10.1016/0896-6273(88)90162-6 · Cited by 7,972
The chemokine system in diverse forms of macrophage activation and polarization
MANTOVANI, A., SICA, A., SOZZANI, S., ALLAVENA, P., VECCHI, A., & LOCATI, M. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.09.015 · Cited by 6,534
Alternative activation of macrophages
Gordon, S. (2003) · Nature Reviews Immunology · doi:10.1038/nri978 · Cited by 6,189
Inflammation and Alzheimer’s disease
Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514
Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291
Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease
Sherrington, R., Rogaev, E. I., Liang, Y., Rogaeva, E. A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li, G., Holman, K., et al. (1995) · Nature · doi:10.1038/375754a0 · Cited by 4,051 · cited 2×
“Missense mutations within the PS1 and PS2 genes are the most common cause of early onset familial AD (Levy-Lahad et al. 1995; Sherrington et al. 1995), but mutations in APP gene have also been seen in more elderly familial cases (Citron et al. 1992).”
BackgroundVassar, R., Bennett, B. D., Babu-Khan, S., Kahn, S., Mendiaz, E. A., Denis, P., Teplow, D. B., Ross, S., Amarante, P., Loeloff, R., et al. (1999) · Science · doi:10.1126/science.286.5440.735 · Cited by 3,876 · cited 2×
“…implicated in the APP cleavage (Zhang et al. 2011), but because a-secretase cleaves within the Ab encoding region, it is not a factor in Ab formation. b-Site APP converting enzyme 1 and 2 are b-secretases, and both have been implicated as major factors in the formation of Ab (Vassar et al. 1999).”
BackgroundDiffusible, nonfibrillar ligands derived from Aβ 1–42 are potent central nervous system neurotoxins
Lambert, M. P., Barlow, A. K., Chromy, B. A., Edwards, C., Freed, R., Liosatos, M., Morgan, T. E., Rozovsky, I., Trommer, B., Viola, K. L., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6448 · Cited by 3,506 · cited 1×
“A large number of studies have proven that Ab has a neurotoxic effect when aggregated in specific forms (Hardy and Selkoe 2002; Lambert et al. 1998; Walsh et al. 2002).”
BackgroundM-1/M-2 Macrophages and the Th1/Th2 Paradigm
Mills, C. D., Kincaid, K., Alt, J. M., Heilman, M. J., & Hill, A. M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.12.6166 · Cited by 3,287
The molecular pathology of Alzheimer's disease
Selkoe, D. J. (1991) · Neuron · doi:10.1016/0896-6273(91)90052-2 · Cited by 2,708
Candidate gene for the chromosome 1 familial Alzheimer’s disease locus
Levy-Lahad, E., Wasco, W., Poorkaj, P., Romano, D. M., Oshima, J., Pettingell, W. H., Yu, C.-E., Jondro, P. D., Schmidt, S. D., Wang, K., et al. (1995) · Science · doi:10.1126/science.7638622 · Cited by 2,577
Inflammatory Blockade Restores Adult Hippocampal Neurogenesis
Monje, M. L., Toda, H., & Palmer, T. D. (2003) · Science · doi:10.1126/science.1088417 · Cited by 2,426
Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway
HEINRICH, P. C., BEHRMANN, I., MÜLLER-NEWEN, G., SCHAPER, F., & GRAEVE, L. (1998) · Biochemical Journal · doi:10.1042/bj3340297 · Cited by 2,130 · cited 2×
“…nitric oxide synthase (NOS), NADPH oxidases, and corresponding toxic intermediates, and reactive oxygen and nitrogen species (Akiyama et al. 2000; Benoit et al. 2008; Brown 2007; Burton et al. 2011; Gutteridge and Halliwell 1989; Heinrich et al. 1998; Pratico et al. 2001; Pratico and Sung 2004).”
BackgroundNew neurons and new memories: how does adult hippocampal neurogenesis affect learning and memory?
Deng, W., Aimone, J. B., & Gage, F. H. (2010) · Nature reviews. Neuroscience · doi:10.1038/nrn2822 · Cited by 2,120 · cited 2×
“The chronic neuroinflammation seen in AD has been shown to be the major contributor to overall suppression of neurogenesis in the SVZ and SGZ ( Deng et al .”
BackgroundJarrett, J. T., Berger, E. P., & Lansbury, P. T. (1993) · Biochemistry · doi:10.1021/bi00069a001 · Cited by 2,022 · cited 2×
“…Ab deposition in Down syndrome and biochemical studies of both Ab40 and Ab42 have shown that the Ab42 fragment tends to aggregate into fibrils more readily than the Ab40 fragment, causing a gradual increase of Ab42 deposition with age (Iwatsubo et al. 1995; Jarrett et al. 1993; Lemere et al. 1996).”
BackgroundGene regulation and DNA damage in the ageing human brain
Lu, T., Pan, Y., Kao, S.-Y., Li, C., Kohane, I., Chan, J., & Yankner, B. A. (2004) · Nature · doi:10.1038/nature02661 · Cited by 1,874
ADULT NEUROGENESIS IN THE MAMMALIAN CENTRAL NERVOUS SYSTEM
Ming, G.-L., & Song, H. (2005) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.28.051804.101459 · Cited by 1,839
The ageing systemic milieu negatively regulates neurogenesis and cognitive function
Villeda, S. A., Luo, J., Mosher, K. I., Zou, B., Britschgi, M., Bieri, G., Stan, T. M., Fainberg, N., Ding, Z., Eggel, A., et al. (2011) · Nature · doi:10.1038/nature10357 · Cited by 1,763
Citron, M., Oltersdorf, T., Haass, C., McConlogue, L., Hung, A. Y., Seubert, P., Vigo-Pelfrey, C., Lieberburg, I., & Selkoe, D. J. (1992) · Nature · doi:10.1038/360672a0 · Cited by 1,757 · cited 1×
“Missense mutations within the PS1 and PS2 genes are the most common cause of early onset familial AD (Levy-Lahad et al. 1995; Sherrington et al. 1995), but mutations in APP gene have also been seen in more elderly familial cases (Citron et al. 1992).”
BackgroundIsolation and quantification of soluble Alzheimer's β-peptide from biological fluids
Seubert, P., Vigo-Pelfrey, C., Esch, F., Lee, M., Dovey, H., Davis, D., Sinha, S., Schiossmacher, M., Whaley, J., Swindlehurst, C., et al. (1992) · Nature · doi:10.1038/359325a0 · Cited by 1,731 · cited 2×
“Secondly, Ab is normally found even in the healthy human brain and in normal cell culture of healthy humans and other mammals (Haass and De Strooper 1999; Seubert et al. 1992; Shoji et al. 1992), and those individuals with APP or c-secretase gene mutations that have higher deposits of Ab”
BackgroundNotch-1 signalling requires ligand-induced proteolytic release of intracellular domain
Schroeter, E. H., Kisslinger, J. A., & Kopan, R. (1998) · Nature · doi:10.1038/30756 · Cited by 1,624
Microglia Shape Adult Hippocampal Neurogenesis through Apoptosis-Coupled Phagocytosis
Sierra, A., Encinas, J. M., Deudero, J. J. P., Chancey, J. H., Enikolopov, G., Overstreet-Wadiche, L. S., Tsirka, S. E., & Maletic-Savatic, M. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.08.014 · Cited by 1,622
Jankowsky, J. L., Fadale, D. J., Anderson, J., Xu, G. M., Gonzales, V., Jenkins, N. A., Copeland, N. G., Lee, M. K., Younkin, L. H., Wagner, S. L., et al. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh019 · Cited by 1,575 · cited 2×
“These findings were reproduced in some AD mouse models, such as the APP ? PS1 mouse (Jankowsky et al. 2004), which demonstrated that there was a distinctive shift from M2 to M1 microglial activation in the hippocampus of aged rodents (Jimenez et al.”
BackgroundResultInflammation is detrimental for neurogenesis in adult brain
Ekdahl, C. T., Claasen, J.-H., Bonde, S., Kokaia, Z., & Lindvall, O. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2234031100 · Cited by 1,559
Remyelination in the CNS: from biology to therapy
Franklin, R. J. M., & ffrench-Constant, C. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2480 · Cited by 1,544
Soluble Amyloid β Peptide Concentration as a Predictor of Synaptic Change in Alzheimer's Disease
Lue, L.-F., Kuo, Y.-M., Roher, A. E., Brachova, L., Shen, Y., Sue, L., Beach, T., Kurth, J. H., Rydel, R. E., & Rogers, J. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65184-x · Cited by 1,530
An english translation of alzheimer’s 1907 paper, “über eine eigenartige erkankung der hirnrinde”
Stelzmann, R. A., Norman Schnitzlein, H., & Reed Murtagh, F. (1995) · Clinical Anatomy · doi:10.1002/ca.980080612 · Cited by 1,455
Production of the Alzheimer Amyloid β Protein by Normal Proteolytic Processing
Shoji, M., Golde, T. E., Ghiso, J., Cheung, T. T., Estus, S., Shaffer, L. M., Cai, X.-D., McKay, D. M., Tintner, R., Frangione, B., et al. (1992) · Science · doi:10.1126/science.1439760 · Cited by 1,447 · cited 2×
“Secondly, Ab is normally found even in the healthy human brain and in normal cell culture of healthy humans and other mammals (Haass and De Strooper 1999; Seubert et al. 1992; Shoji et al. 1992), and those individuals with APP or c-secretase gene mutations that have higher deposits of Ab”
BackgroundHolmes, C., Boche, D., Wilkinson, D., Yadegarfar, G., Hopkins, V., Bayer, A., Jones, R. W., Bullock, R., Love, S., Neal, J. W., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61075-2 · Cited by 1,416 · cited 1×
“Firstly, therapeutics against Ab, though successful in removing Ab deposits in animal models and humans, do not stop the progression of AD, meaning it is not the reversible cause of dementia (Holmes et al. 2008; Salloway et al. 2009).”
BackgroundCleavage of Amyloid β Peptide During Constitutive Processing of Its Precursor
Esch, F. S., Keim, P. S., Beattie, E. C., Blacher, R. W., Culwell, A. R., Oltersdorf, T., McClure, D., & Ward, P. J. (1990) · Science · doi:10.1126/science.2111583 · Cited by 1,410
Neuropathology of older persons without cognitive impairment from two community-based studies
Bennett, D. A., Schneider, J. A., Arvanitakis, Z., Kelly, J. F., Aggarwal, N. T., Shah, R. C., & Wilson, R. S. (2006) · Neurology · doi:10.1212/01.wnl.0000219668.47116.e6 · Cited by 1,336 · cited 2×
“cognition who never develop dementia show significant levels of amyloid burden in the brain (Aizenstein et al. 2008; Bennett et al. 2006).”
BackgroundMacrophage Polarization in Bacterial Infections
Benoit, M., Desnues, B., & Mege, J.-L. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.6.3733 · Cited by 1,329
Neural mechanisms of ageing and cognitive decline
Bishop, N. A., Lu, T., & Yankner, B. A. (2010) · Nature · doi:10.1038/nature08983 · Cited by 1,323 · cited 1×
“…analyses of brain tissue from normally aging humans and mice showed significant up-regulation of certain genes that occurred with age, and about half of those genes were associated with inflammation and oxidative stress (Bishop et al. 2010; Loerch et al. 2008; Lu et al. 2004; Prolla 2002).”
BackgroundRavetch, J. V., & Lanier, L. L. (2000) · Science · doi:10.1126/science.290.5489.84 · Cited by 1,283
Ravetch, J. V., & Kinet, J. P. (1991) · Annual Review of Immunology · doi:10.1146/annurev.iy.09.040191.002325 · Cited by 1,229
A Transcriptively Active Complex of APP with Fe65 and Histone Acetyltransferase Tip60
Cao, X., & Südhof, T. C. (2001) · Science · doi:10.1126/science.1058783 · Cited by 1,202
Frequent amyloid deposition without significant cognitive impairment among the elderly
Aizenstein, H. J., Nebes, R. D., Saxton, J. A., Price, J. C., Mathis, C. A., Tsopelas, N. D., Ziolko, S. K., James, J. A., Snitz, B. E., Houck, P. R., et al. (2008) · Archives of Neurology · doi:10.1001/archneur.65.11.1509 · Cited by 1,059
Gene-expression profile of the ageing brain in mice
Lee, C.-K., Weindruch, R., & Prolla, T. A. (2000) · Nature Genetics · doi:10.1038/77046 · Cited by 1,055
Down-Regulation of the Macrophage Lineage Through Interaction with OX2 (CD200)
Hoek, R. M., Ruuls, S. R., Murphy, C. A., Wright, G. J., Goddard, R., Zurawski, S. M., Blom, B., Homola, M. E., Streit, W. J., Brown, M. H., et al. (2000) · Science · doi:10.1126/science.290.5497.1768 · Cited by 1,022
Essential role of MD-2 in LPS responsiveness and TLR4 distribution
Nagai, Y., Akashi, S., Nagafuku, M., Ogata, M., Iwakura, Y., Akira, S., Kitamura, T., Kosugi, A., Kimoto, M., & Miyake, K. (2002) · Nature Immunology · doi:10.1038/ni809 · Cited by 1,020
Hippocampal synaptic loss in early Alzheimer's disease and mild cognitive impairment
Scheff, S. W., Price, D. A., Schmitt, F. A., & Mufson, E. J. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.09.012 · Cited by 1,017 · cited 1×
“AD patients also exhibit an extensive loss of synapses and neurons, namely in the temporal and frontal cortices and hippocampi (Davies et al. 1987; Scheff et al. 2006, 2007).”
BackgroundBroad Expression of Toll-Like Receptors in the Human Central Nervous System
Bsibsi, M., Ravid, R., Gveric, D., & van Noort, J. M. (2002) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/61.11.1013 · Cited by 999
Stress Hormones, Proinflammatory and Antiinflammatory Cytokines, and Autoimmunity
ELENKOV, I. J., & CHROUSOS, G. P. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04229.x · Cited by 983
APP processing in Alzheimer’s disease.
Zhang, Y.-W., Thompson, R., Zhang, H., & Xu, H. (2011) · Molecular Brain · doi:10.1186/1756-6606-4-3 · Cited by 983
Increased hippocampal neurogenesis in Alzheimer's disease
Jin, K., Peel, A. L., Mao, X. O., Xie, L., Cottrell, B. A., Henshall, D. C., & Greenberg, D. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2634794100 · Cited by 971 · cited 1×
“2006 ; Jin et al .”
Butovsky, O., Ziv, Y., Schwartz, A., Landa, G., Talpalar, A. E., Pluchino, S., Martino, G., & Schwartz, M. (2006) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2005.10.006 · Cited by 923
Heterogeneity of Microglial Activation in the Innate Immune Response in the Brain
Colton, C. A. (2009) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-009-9164-4 · Cited by 877
The role of presenilin cofactors in the γ-secretase complex
Takasugi, N., Tomita, T., Hayashi, I., Tsuruoka, M., Niimura, M., Takahashi, Y., Thinakaran, G., & Iwatsubo, T. (2003) · Nature · doi:10.1038/nature01506 · Cited by 867
Synaptic alterations in CA1 in mild Alzheimer disease and mild cognitive impairment
Scheff, S. W., Price, D. A., Schmitt, F. A., DeKosky, S. T., & Mufson, E. J. (2007) · Neurology · doi:10.1212/01.wnl.0000260698.46517.8f · Cited by 824
Amyloid β-Protein and the Genetics of Alzheimer's Disease
Selkoe, D. J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.31.18295 · Cited by 799
Non‐motor symptoms in Parkinson’s disease
Poewe, W. (2008) · European Journal of Neurology · doi:10.1111/j.1468-1331.2008.02056.x · Cited by 782
Pivotal role for neuronal Toll-like receptors in ischemic brain injury and functional deficits
Tang, S.-C., Arumugam, T. V., Xu, X., Cheng, A., Mughal, M. R., Jo, D. G., Lathia, J. D., Siler, D. A., Chigurupati, S., Ouyang, X., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702553104 · Cited by 779
Praticò, D., Uryu, K., Leight, S., Trojanoswki, J. Q., & Lee, V. M.-Y. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-12-04183.2001 · Cited by 777
γ-Secretase is a membrane protein complex comprised of presenilin, nicastrin, aph-1, and pen-2
Kimberly, W. T., LaVoie, M. J., Ostaszewski, B. L., Ye, W., Wolfe, M. S., & Selkoe, D. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1037392100 · Cited by 763
A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease
Salloway, S., Sperling, R., Gilman, S., Fox, N. C., Blennow, K., Raskind, M., Sabbagh, M., Honig, L. S., Doody, R., van Dyck, C. H., et al. (2009) · Neurology · doi:10.1212/wnl.0b013e3181c67808 · Cited by 753
Identification of Ia glycoproteins in rat thymus and purification from rat spleen
McMaster, W. R., & Williams, A. F. (1979) · European Journal of Immunology · doi:10.1002/eji.1830090603 · Cited by 678
Davies, C. A., Mann, D. M. A., Sumpter, P. Q., & Yates, P. O. (1987) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(87)90057-8 · Cited by 628
Matrix metalloproteinases and their multiple roles in neurodegenerative diseases
Rosenberg, G. A. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70016-x · Cited by 594
CD14 and Toll-Like Receptors 2 and 4 Are Required for Fibrillar Aβ-Stimulated Microglial Activation
Reed-Geaghan, E. G., Savage, J. C., Hise, A. G., & Landreth, G. E. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3158-09.2009 · Cited by 591 · cited 4×
“TLRs are ubiquitously expressed and are often expressed on the plasma membranes of immune cells and glial cells, including microglia, astrocytes, and neurons (Bsibsi et al. 2002; Tang et al. 2007).”
BackgroundInfluentialTGF-β1 promotes microglial amyloid-β clearance and reduces plaque burden in transgenic mice
Wyss-Coray, T., Lin, C., Yan, F., Yu, G.-Q., Rohde, M., McConlogue, L., Masliah, E., & Mucke, L. (2001) · Nature Medicine · doi:10.1038/87945 · Cited by 587
Lemere, C. A., Blusztajn, J. K., Yamaguchi, H., Wisniewski, T., Saido, T. C., & Selkoe, D. J. (1996) · Neurobiology of Disease · doi:10.1006/nbdi.1996.0003 · Cited by 584 · cited 2×
“…Ab deposition in Down syndrome and biochemical studies of both Ab40 and Ab42 have shown that the Ab42 fragment tends to aggregate into fibrils more readily than the Ab40 fragment, causing a gradual increase of Ab42 deposition with age (Iwatsubo et al. 1995; Jarrett et al. 1993; Lemere et al. 1996).”
BackgroundBaek, S. H., Ohgi, K. A., Rose, D. W., Koo, E. H., Glass, C. K., & Rosenfeld, M. G. (2002) · Cell · doi:10.1016/s0092-8674(02)00809-7 · Cited by 558
Secretion of β-amyloid precursor protein cleaved at the amino terminus of the β-amyloid peptide
Seubert, P., Oltersdorf, T., Lee, M. G., Barbour, R., Blomquist, C., Davis, D. L., Bryant, K., Fritz, L. C., Galasko, D., Thal, L. J., et al. (1993) · Nature · doi:10.1038/361260a0 · Cited by 552
Brain cytochrome oxidase in Alzheimer's disease
Kish, S. J., Bergeron, C., Rajput, A., Dozic, S., Mastrogiacomo, F., Chang, L., Wilson, J. M., DiStefano, L. M., & Nobrega, J. N. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb09439.x · Cited by 537 · cited 1×
“There is subsequent production and buildup of reactive intermediates and oxygen species that lead to oxidative injury (Gutowicz 2011; Kish et al. 1992).”
BackgroundEdison, P., Archer, H. A., Gerhard, A., Hinz, R., Pavese, N., Turkheimer, F. E., Hammers, A., Tai, Y. F., Fox, N., Kennedy, A., et al. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.08.001 · Cited by 513 · cited 3×
“Using two carbon 11 ([ 11 C] )-labeled positron emission tomographic imaging agents, Pittsburgh Compound B (PIB, an Ab marker) and PK-11195 (a benzodiazepine receptor ligand and a microglial marker), several groups examined if PIB and PK11195 binding correlated with cognitive function of AD patients.”
BackgroundElevated circulating tumor necrosis factor levels in Alzheimer's disease
Fillit, H., Ding, W., Buee, L., Kalman, J., Altstiel, L., Lawlor, B., & Wolf-Klein, G. (1991) · Neuroscience Letters · doi:10.1016/0304-3940(91)90490-k · Cited by 512
Deng, W., Saxe, M. D., Gallina, I. S., & Gage, F. H. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3362-09.2009 · Cited by 493 · cited 1×
“2007 ; Deng et al .”
Role of toll-like receptor signalling in A uptake and clearance
Tahara, K., Kim, H.-D., Jin, J.-J., Maxwell, J. A., Li, L., & Fukuchi, K.-I. (2006) · Brain · doi:10.1093/brain/awl249 · Cited by 493 · cited 1×
“( 2008 ) ; Tahara et al .”
Haigis, M. C., & Yankner, B. A. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.10.002 · Cited by 488
Alzheimer's disease: synaptic dysfunction and Aβ
Shankar, G. M., & Walsh, D. M. (2009) · Molecular Neurodegeneration · doi:10.1186/1750-1326-4-48 · Cited by 486
Interleukin‐6 and α‐2‐macroglobulin indicate an acute‐phase state in Alzheimer's disease cortices
Bauer, J., Strauss, S., Schreiter-Gasser, U., Ganter, U., Schlegel, P., Witt, I., Yolk, B., & Berger, M. (1991) · FEBS Letters · doi:10.1016/0014-5793(91)80737-n · Cited by 483
Kopan, R., Schroeter, E. H., Weintraub, H., & Nye, J. S. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.4.1683 · Cited by 470
Structure and Function of Human and Murine Receptors for IgG
Unkeless, J. C., Scigliano, E., & Freedman, V. H. (1988) · Annual Review of Immunology · doi:10.1146/annurev.iy.06.040188.001343 · Cited by 470
Haughey, N. J., Nath, A., Chan, S. L., Borchard, A. C., Rao, M. S., & Mattson, M. P. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01267.x · Cited by 466 · cited 1×
“In in vitro cultures of NPCs , it was found that aggregated Ab42 inhibited neuronal differenti - ation ( Haughey et al .”
BackgroundA critical function for CD200 in lung immune homeostasis and the severity of influenza infection
Snelgrove, R. J., Goulding, J., Didierlaurent, A. M., Lyonga, D., Vekaria, S., Edwards, L., Gwyer, E., Sedgwick, J. D., Barclay, A. N., & Hussell, T. (2008) · Nature Immunology · doi:10.1038/ni.1637 · Cited by 460
Immune System Response in Alzheimer's Disease
McGeer, P. L., Akiyama, H., Itagaki, S., & McGeer, E. G. (1989) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100029863 · Cited by 459
Dayer, A. G., Cleaver, K. M., Abouantoun, T., & Cameron, H. A. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200407053 · Cited by 454
See no evil, hear no evil, do no evil: the lessons of immune privilege
Niederkorn, J. Y. (2006) · Nature Immunology · doi:10.1038/ni1328 · Cited by 447
Prominent neurodegeneration and increased plaque formation in complement-inhibited Alzheimer's mice
Wyss-Coray, T., Yan, F., Lin, A. H.-T., Lambris, J. D., Alexander, J. J., Quigg, R. J., & Masliah, E. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.162350199 · Cited by 446
Differential expression of FIZZ1 and Ym1 in alternatively versus classically activated macrophages
Raes, G., De Baetselier, P., Noël, W., Beschin, A., Brombacher, F., & Hassanzadeh Gh., G. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.71.4.597 · Cited by 443
Characterization of the CD200 Receptor Family in Mice and Humans and Their Interactions with CD200
Wright, G. J., Cherwinski, H., Foster-Cuevas, M., Brooke, G., Puklavec, M. J., Bigler, M., Song, Y., Jenmalm, M., Gorman, D., McClanahan, T., et al. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.6.3034 · Cited by 434
Shaftel, S. S., Kyrkanides, S., Olschowka, J. A., Miller, J.-N. H., Johnson, R. E., & O’Banion, M. K. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31450 · Cited by 433 · cited 1×
“( 2007 ) M1 : APP IL - 1b TG : MHCII , astrogliosis ND ND ; Shaftel et al .”
BackgroundAlzheimer's disease. A double-labeling immunohistochemical study of senile plaques.
Dickson, D. W., Farlo, J., Davies, P., Crystal, H., Fuld, P. A., & Yen, S. H. (1988) · PubMed · Cited by 427
Blocking TGF-β–Smad2/3 innate immune signaling mitigates Alzheimer-like pathology
Town, T., Laouar, Y., Pittenger, C., Mori, T., Szekely, C. A., Tan, J., Duman, R. S., & Flavell, R. A. (2008) · Nature Medicine · doi:10.1038/nm1781 · Cited by 422 · cited 1×
“( 2006 ) M2c ; APP DN TGF - bR TG : Dendritic cells ; Astrogliosis ND : ; Town et al .”
BackgroundAdult neurogenesis and repair of the adult CNS with neural progenitors, precursors, and stem cells
Emsley, J. G., Mitchell, B. D., Kempermann, G., & Macklis, J. D. (2005) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2005.04.002 · Cited by 399
Expression profiles for macrophage alternative activation genes in AD and in mouse models of AD.
(2006) · Journal of Neuroinflammation · doi:10.1186/1742-2094-3-27 · Cited by 393 · cited 6×
“These include genes that repair damage to the extracellular matrix, such as arginase 1 (ARG1) (Gomi et al. 2011; Jimenez et al. 2008), mannose receptor (Akiyama et al. 2000), found in inflammatory zone 1, and chitinase 3-like 3 (YM1) (Colton et al. 2006a; Raes et al. 2002).”
BackgroundInfluentialHe, P., Zhong, Z., Lindholm, K., Berning, L., Lee, W., Lemere, C., Staufenbiel, M., Li, R., & Shen, Y. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200705042 · Cited by 390 · cited 1×
“activators enhanced Ab clearance (He et al. 2007; Yamamoto et al. 2007, 2008).”
BackgroundThe Presenilins in Alzheimer's Disease--Proteolysis Holds the Key
Haass, C., & Strooper, B. D. (1999) · Science · doi:10.1126/science.286.5441.916 · Cited by 388
Wright, G. J., Puklavec, M. J., Willis, A. C., Hoek, R. M., Sedgwick, J. D., Brown, M. H., & Barclay, A. N. (2000) · Immunity · doi:10.1016/s1074-7613(00)00023-6 · Cited by 388
Butovsky, O., Koronyo-Hamaoui, M., Kunis, G., Ophir, E., Landa, G., Cohen, H., & Schwartz, M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604681103 · Cited by 388 · cited 3×
“Microglia stimulated by IL-4 have a decrease in TNF-a production and an increase in secretion of IGF-1, and they also induce neurogenesis in vitro (Butovsky et al. 2005, 2006b).”
BackgroundAmyloid β protein (Aβ) deposition: Aβ42(43) precedes Aβ40 in down Syndrome
Iwatsubo, T., Mann, D. M. A., Odaka, A., Suzuki, N., & Ihara, Y. (1995) · Annals of Neurology · doi:10.1002/ana.410370305 · Cited by 384
Jimenez, S., Baglietto-Vargas, D., Caballero, C., Moreno-Gonzalez, I., Torres, M., Sanchez-Varo, R., Ruano, D., Vizuete, M., Gutierrez, A., & Vitorica, J. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3024-08.2008 · Cited by 383 · cited 6×
“These include genes that repair damage to the extracellular matrix, such as arginase 1 (ARG1) (Gomi et al. 2011; Jimenez et al. 2008), mannose receptor (Akiyama et al. 2000), found in inflammatory zone 1, and chitinase 3-like 3 (YM1) (Colton et al. 2006a; Raes et al. 2002).”
BackgroundInfluentialYamamoto, M., Kiyota, T., Horiba, M., Buescher, J. L., Walsh, S. M., Gendelman, H. E., & Ikezu, T. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.060378 · Cited by 367
Self-citationMicroglial activation and amyloid deposition in mild cognitive impairment: A PET study
Okello, A., Edison, P., Archer, H. A., Turkheimer, F. E., Kennedy, J., Bullock, R., Walker, Z., Kennedy, A., Fox, N., Rossor, M., et al. (2009) · Neurology · doi:10.1212/01.wnl.0000338622.27876.0d · Cited by 367
Butovsky, O., Talpalar, A. E., Ben-Yaakov, K., & Schwartz, M. (2005) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2005.03.005 · Cited by 365
Genetic aspects of Alzheimer disease.
Bird, T. D. (2008) · Genetics in Medicine · doi:10.1097/gim.0b013e31816b64dc · Cited by 356
Deficiency in neuronal TGF-β signaling promotes neurodegeneration and Alzheimer’s pathology
Tesseur, I., Zou, K., Esposito, L., Bard, F., Berber, E., Can, J. V., Lin, A. H., Crews, L., Tremblay, P., Mathews, P., et al. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27341 · Cited by 355
Neuroinflammation in Alzheimer's Disease and Mild Cognitive Impairment: A Field in Its Infancy
McGeer, E. G., & McGeer, P. L. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-1219 · Cited by 346
Nitration of Tyrosine 10 Critically Enhances Amyloid β Aggregation and Plaque Formation
Kummer, M. P., Hermes, M., Delekarte, A., Hammerschmidt, T., Kumar, S., Terwel, D., Walter, J., Pape, H.-C., König, S., Roeber, S., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.07.001 · Cited by 336 · cited 2×
“In the most recent publication, however, Kummer et al. (2011) found that APP ?”
Evolution of the Aging Brain Transcriptome and Synaptic Regulation
Loerch, P. M., Lu, T., Dakin, K. A., Vann, J. M., Isaacs, A., Geula, C., Wang, J., Pan, Y., Gabuzda, D. H., Li, C., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003329 · Cited by 334 · cited 1×
“…analyses of brain tissue from normally aging humans and mice showed significant up-regulation of certain genes that occurred with age, and about half of those genes were associated with inflammation and oxidative stress (Bishop et al. 2010; Loerch et al. 2008; Lu et al. 2004; Prolla 2002).”
BackgroundNeuroinflammation Associated with Aging Sensitizes the Brain to the Effects of Infection or Stress
Sparkman, N. L., & Johnson, R. W. (2008) · Neuroimmunomodulation · doi:10.1159/000156474 · Cited by 332
Boekhoorn, K., Joels, M., & Lucassen, P. J. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.04.017 · Cited by 325
Patel, N. S., Paris, D., Mathura, V., Quadros, A. N., Crawford, F. C., & Mullan, M. J. (2005) · Journal of Neuroinflammation · doi:10.1186/1742-2094-2-9 · Cited by 319
Mechanisms of inflammatory neurodegeneration: iNOS and NADPH oxidase
Brown, G. C. (2007) · Biochemical Society Transactions · doi:10.1042/bst0351119 · Cited by 316
Regulation of Macrophage Chemokine Expression by Lipopolysaccharide In Vitro and In Vivo
Kopydlowski, K. M., Salkowski, C. A., Cody, M. J., van Rooijen, N., Major, J., Hamilton, T. A., & Vogel, S. N. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.3.1537 · Cited by 313
Dissection of Amyloid-β Precursor Protein-dependent Transcriptional Transactivation
Cao, X., & Südhof, T. C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402248200 · Cited by 309
Development of neural stem cell in the adult brain
Duan, X., Kang, E., Liu, C. Y., Ming, G.-L., & Song, H. (2008) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2008.04.001 · Cited by 306
Evidence for glial-mediated inflammation in aged APPSW transgenic mice
Benzing, W. C., Wujek, J. R., Ward, E. K., Shaffer, D., Ashe, K. H., Younkin, S. G., & Brunden, K. R. (1999) · Neurobiology of Aging · doi:10.1016/s0197-4580(99)00065-2 · Cited by 299
Actin-ATP Hydrolysis Is a Major Energy Drain for Neurons
Bernstein, B. W., & Bamburg, J. R. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-01-00002.2003 · Cited by 298
Matrix metalloproteinases degrade myelin basic protein
Chandler, S., Coates, R., Gearing, A., Lury, J., Wells, G., & Bone, E. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)12173-0 · Cited by 294
Maeda, A., & Sobel, R. A. (1996) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199603000-00005 · Cited by 291
Haga, S., Akai, K., & Ishii, T. (1989) · Acta Neuropathologica · doi:10.1007/bf00687883 · Cited by 286
Microbial recognition by Toll-like receptors
Takeda, K., & Akira, S. (2004) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2003.10.002 · Cited by 285 · cited 2×
“…activation via the TLR4 complex, which then triggers an intracellular signaling cascade that activates NF-jB and three types of mitogen-activated protein kinases (MAPKs): extracellular signal-regulated kinase (Erk), c-Jun N-terminal kinase (JNK), and p38 (Nagai et al. 2002; Takeda and Akira 2004).”
BackgroundAdult Hippocampal Neurogenesis, Synaptic Plasticity and Memory: Facts and Hypotheses
Bruel-Jungerman, E., Rampon, C., & Laroche, S. (2007) · Reviews in the Neurosciences · doi:10.1515/revneuro.2007.18.2.93 · Cited by 282
SOCS1 and SOCS3 in the control of CNS immunity
Baker, B. J., Akhtar, L. N., & Benveniste, E. N. (2009) · Trends in Immunology · doi:10.1016/j.it.2009.07.001 · Cited by 276
Jin, J.-J., Kim, H.-D., Maxwell, J. A., Li, L., & Fukuchi, K.-I. (2008) · Journal of Neuroinflammation · doi:10.1186/1742-2094-5-23 · Cited by 275
Adult‐born neurons are necessary for extended contextual discrimination
Tronel, S., Belnoue, L., Grosjean, N., Revest, J., Piazza, P., Koehl, M., & Abrous, D. N. (2012) · Hippocampus · doi:10.1002/hipo.20895 · Cited by 274
Song, M., Jin, J., Lim, J.-E., Kou, J., Pattanayak, A., Rehman, J. A., Kim, H.-D., Tahara, K., Lalonde, R., & Fukuchi, K.-I. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-92 · Cited by 273
A physiologic signaling role for the γ-secretase-derived intracellular fragment of APP
Leissring, M. A., Murphy, M. P., Mead, T. R., Akbari, Y., Sugarman, M. C., Jannatipour, M., Anliker, B., Müller, U., Saftig, P., De Strooper, B., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.072033799 · Cited by 273
Reviews: Current Concepts in Alzheimer's Disease: A Multidisciplinary Review
Minati, L., Edginton, T., Grazia Bruzzone, M., & Giaccone, G. (2009) · American Journal of Alzheimer's Disease & Other Dementias® · doi:10.1177/1533317508328602 · Cited by 268
Walker, D. G., Dalsing-Hernandez, J. E., Campbell, N. A., & Lue, L.-F. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2008.09.003 · Cited by 267
Janelsins, M. C., Mastrangelo, M. A., Oddo, S., LaFerla, F. M., Federoff, H. J., & Bowers, W. J. (2005) · Journal of Neuroinflammation · doi:10.1186/1742-2094-2-23 · Cited by 260
Amyloid β-peptide induces apoptosis-related events in synapses and dendrites
Mattson, M. P., Partin, J., & Begley, J. G. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00763-x · Cited by 259
Lyons, A., Downer, E. J., Crotty, S., Nolan, Y. M., Mills, K. H. G., & Lynch, M. A. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.1781-07.2007 · Cited by 258 · cited 4×
“2010 ; Lyons et al .”
BackgroundInfluentialApelt, J., & Schliebs, R. (2001) · Brain Research · doi:10.1016/s0006-8993(00)03176-0 · Cited by 257
Dual Roles for Perivascular Macrophages in Immune-to-Brain Signaling
Serrats, J., Schiltz, J. C., García-Bueno, B., van Rooijen, N., Reyes, T. M., & Sawchenko, P. E. (2010) · Neuron · doi:10.1016/j.neuron.2009.11.032 · Cited by 253
1 Iron toxicity and oxygen radicals
Gutteridge, J. M. C., & Halliwell, B. (1989) · Baillière's Clinical Haematology · doi:10.1016/s0950-3536(89)80017-4 · Cited by 253
Bruck, A. (2004) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2003.031237 · Cited by 246
Molecular Mechanisms of CD200 Inhibition of Mast Cell Activation
Zhang, S., Cherwinski, H., Sedgwick, J. D., & Phillips, J. H. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.11.6786 · Cited by 242
Interleukin-6 Mediates the Increase in NADPH-Oxidase in the Ketamine Model of Schizophrenia
Behrens, M. M., Ali, S. S., & Dugan, L. L. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.4457-08.2008 · Cited by 241 · cited 1×
“Pro - inflammatory molecules such as TNF - a and IL - 6 have been shown to contribute to mitochondrial dysfunction during brain inflammation both in vitro and in vivo ( Behrens et al .”
BackgroundNeurogenesis in Rats After Focal Cerebral Ischemia is Enhanced by Indomethacin
Hoehn, B. D., Palmer, T. D., & Steinberg, G. K. (2005) · Stroke · doi:10.1161/01.str.0000190020.30282.cc · Cited by 241
Barclay, A. N. (1981) · PubMed · Cited by 240
Immune Influence on Adult Neural Stem Cell Regulation and Function
Carpentier, P. A., & Palmer, T. D. (2009) · Neuron · doi:10.1016/j.neuron.2009.08.038 · Cited by 234
Interleukin-1β, but not interleukin-6, impairs spatial navigation learning
Oitzl, M. S., van Oers, H., Schöbitz, B., & Ron de Kloet, E. (1993) · Brain Research · doi:10.1016/0006-8993(93)90468-3 · Cited by 230
Lipid peroxidation and oxidative imbalance: early functional events in Alzheimer's disease
Praticò, D., & Sung, S. (2004) · Journal of Alzheimer s Disease · doi:10.3233/jad-2004-6209 · Cited by 229 · cited 3×
“…nitric oxide synthase (NOS), NADPH oxidases, and corresponding toxic intermediates, and reactive oxygen and nitrogen species (Akiyama et al. 2000; Benoit et al. 2008; Brown 2007; Burton et al. 2011; Gutteridge and Halliwell 1989; Heinrich et al. 1998; Pratico et al. 2001; Pratico and Sung 2004).”
BackgroundBroderick, C., Hoek, R. M., Forrester, J. V., Liversidge, J., Sedgwick, J. D., & Dick, A. D. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64444-6 · Cited by 225
Sustained hippocampal IL-1β overexpression impairs contextual and spatial memory in transgenic mice
Hein, A. M., Stasko, M. R., Matousek, S. B., Scott-McKean, J. J., Maier, S. F., Olschowka, J. A., Costa, A. C. S., & O’Banion, M. K. (2010) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2009.10.002 · Cited by 224
Janelsins, M. C., Mastrangelo, M. A., Park, K. M., Sudol, K. L., Narrow, W. C., Oddo, S., LaFerla, F. M., Callahan, L. M., Federoff, H. J., & Bowers, W. J. (2008) · The American Journal of Pathology · doi:10.2353/ajpath.2008.080528 · Cited by 220
Kiyota, T., Ingraham, K. L., Swan, R. J., Jacobsen, M. T., Andrews, S. J., & Ikezu, T. (2012) · Gene Therapy · doi:10.1038/gt.2011.126 · Cited by 217
Self-citationMagavi, S. S. P., Mitchell, B. D., Szentirmai, O., Carter, B. S., & Macklis, J. D. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.2250-05.2005 · Cited by 216
Lund, S., Christensen, K. V., Hedtjärn, M., Mortensen, A. L., Hagberg, H., Falsig, J., Hasseldam, H., Schrattenholz, A., Pörzgen, P., & Leist, M. (2006) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.07.007 · Cited by 212
Kiyota, T., Okuyama, S., Swan, R. J., Jacobsen, M. T., Gendelman, H. E., & Ikezu, T. (2010) · The FASEB Journal · doi:10.1096/fj.10-155317 · Cited by 212
Self-citationRole of Interleukin-4 in Regulation of Age-related Inflammatory Changes in the Hippocampus
Nolan, Y., Maher, F. O., Martin, D. S., Clarke, R. M., Brady, M. T., Bolton, A. E., Mills, K. H. G., & Lynch, M. A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m412170200 · Cited by 209
White matter damage is associated with matrix metalloproteinases in vascular dementia
Rosenberg, G. A., Sullivan, N., & Esiri, M. M. (2001) · Stroke · doi:10.1161/01.str.32.5.1162 · Cited by 207
The rate of conversion of mild cognitive impairment to dementia: predictive role of depression
Gabryelewicz, T., Styczynska, M., Luczywek, E., Barczak, A., Pfeffer, A., Androsiuk, W., Chodakowska‐Zebrowska, M., Wasiak, B., Peplonska, B., & Barcikowska, M. (2007) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1716 · Cited by 199
Wen, P. H., Hof, P. R., Chen, X., Gluck, K., Austin, G., Younkin, S. G., Younkin, L. H., DeGasperi, R., Gama Sosa, M. A., Robakis, N. K., et al. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2004.04.002 · Cited by 189
Samavati, L., Lee, I., Mathes, I., Lottspeich, F., & Hüttemann, M. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801954200 · Cited by 184
Innate and Adaptive Immune Responses of the Central Nervous System
Bailey, S. L., Carpentier, P. A., McMahon, E. J., Begolka, W. S., & Miller, S. D. (2006) · Critical Reviews™ in Immunology · doi:10.1615/critrevimmunol.v26.i2.40 · Cited by 182
Martin, M. D. P. (2008) · Archives of Neurology · doi:10.1001/archneur.65.12.noc80051 · Cited by 181
Kretz-Rommel, A., Qin, F., Dakappagari, N., Ravey, E. P., McWhirter, J., Oltean, D., Frederickson, S., Maruyama, T., Wild, M. A., Nolan, M.-J., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.9.5595 · Cited by 178
Inflammation Regulates Functional Integration of Neurons Born in Adult Brain
Jakubs, K., Bonde, S., Iosif, R. E., Ekdahl, C. T., Kokaia, Z., Kokaia, M., & Lindvall, O. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.3240-08.2008 · Cited by 177
Zell, R., Geck, P., Werdan, K., & Boekstegers, P. (1997) · Molecular and Cellular Biochemistry · doi:10.1023/a:1006896832582 · Cited by 175
Yokokura, M., Mori, N., Yagi, S., Yoshikawa, E., Kikuchi, M., Yoshihara, Y., Wakuda, T., Sugihara, G., Takebayashi, K., Suda, S., et al. (2011) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-010-1612-0 · Cited by 174
Plunkett, J. A., Yu, C.-G., Easton, J. M., Bethea, J. R., & Yezierski, R. P. (2001) · Experimental Neurology · doi:10.1006/exnr.2000.7604 · Cited by 174
Age-related neuroinflammatory changes negatively impact on neuronal function
Lynch, M. A. (2010) · Frontiers in Aging Neuroscience · doi:10.3389/neuro.24.006.2009 · Cited by 174
Zhao, W., Xie, W., Xiao, Q., Beers, D. R., & Appel, S. H. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04172.x · Cited by 171
Choi, S. H., Veeraraghavalu, K., Lazarov, O., Marler, S., Ransohoff, R. M., Ramirez, J. M., & Sisodia, S. S. (2008) · Neuron · doi:10.1016/j.neuron.2008.07.033 · Cited by 170
Neuroinflammation and regeneration in the early stages of Alzheimer's disease pathology
Hoozemans, J. J. M., Veerhuis, R., Rozemuller, J. M., & Eikelenboom, P. (2006) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2005.11.001 · Cited by 168
Mechanisms of neurofibrillary degeneration and the formation of neurofibrillary tangles
Iqbal, K., Alonso, A. D. C., Gong, C., Khatoon, S., Pei, J. ‐., Wang, J. Z., & Grundke, I. (1998) · Journal of neural transmission. Supplementum · doi:10.1007/978-3-7091-6467-9_15 · Cited by 166
Long Term Potentiation Is Impaired in Membrane Glycoprotein CD200-deficient Mice
Costello, D. A., Lyons, A., Denieffe, S., Browne, T. C., Cox, F., & Lynch, M. A. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.280826 · Cited by 164
Clark, M. J., Gagnon, J., Williams, A. F., & Barclay, A. N. (1985) · The EMBO Journal · doi:10.1002/j.1460-2075.1985.tb02324.x · Cited by 164
Chitnis, T., Imitola, J., Wang, Y., Elyaman, W., Chawla, P., Sharuk, M., Raddassi, K., Bronson, R. T., & Khoury, S. J. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.060677 · Cited by 164
Wiley, C. A., Lopresti, B. J., Venneti, S., Price, J., Klunk, W. E., DeKosky, S. T., & Mathis, C. A. (2009) · Archives of Neurology · doi:10.1001/archneurol.2008.511 · Cited by 163
Maher, F. O., Nolan, Y. M., & Lynch, M. A. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.07.002 · Cited by 162
Wilcock, D. M., Lewis, M. R., Van Nostrand, W. E., Davis, J., Previti, M. L., Gharkholonarehe, N., Vitek, M. P., & Colton, C. A. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.5066-07.2008 · Cited by 162
Lynch, A. M., Walsh, C., Delaney, A., Nolan, Y. M., Campbell, V. A., & Lynch, M. A. (2004) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02157.x · Cited by 161
The complex of microglial cells and amyloid star in three-dimensional reconstruction
Wegiel, J., & Wisniewski, H. M. (1990) · Acta Neuropathologica · doi:10.1007/bf00334499 · Cited by 161
Abbas, N., Bednar, I., Mix, E., Marie, S., Paterson, D., Ljungberg, A., Morris, C., Winblad, B., Nordberg, A., & Zhu, J. (2002) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(02)00050-4 · Cited by 161
Neuroimmune Mechanisms in Alzheimer Disease Pathogenesis
McGeer, P. L., Rogers, J., & McGeer, E. G. (1994) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-199408030-00001 · Cited by 155
Kadir, A., Marutle, A., Gonzalez, D., Schöll, M., Almkvist, O., Mousavi, M. T., Mustafiz, T., Darreh‐Shori, T., Nennesmo, I., & Nordberg, A. K. (2010) · Brain · doi:10.1093/brain/awq349 · Cited by 154
Perturbed Neurogenesis in the Adult Hippocampus Associated with Presenilin-1 A246E Mutation
Chevallier, N. L., Soriano, S., Kang, D. E., Masliah, E., Hu, G., & Koo, E. H. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62962-8 · Cited by 152
Essential Roles for Dok2 and RasGAP in CD200 Receptor-Mediated Regulation of Human Myeloid Cells
Mihrshahi, R., Barclay, A. N., & Brown, M. H. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901531 · Cited by 148
Olfaction in Neurodegenerative Disorder
Hawkes, C. H. (2006) · KARGER eBooks · doi:10.1159/000093759 · Cited by 144
Butovsky, O., Koronyo‐Hamaoui, M., Kunis, G., Ophir, E., Landa, G., Cohen, H., & Schwartz, M. (2006) · Cited by 144
IL‐4 attenuates the neuroinflammation induced by amyloid‐β in vivo and in vitro
Lyons, A., Griffin, R. J., Costelloe, C., Clarke, R. M., & Lynch, M. A. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04370.x · Cited by 139
Copland, D. A., Calder, C. J., Raveney, B. J. E., Nicholson, L. B., Phillips, J. H., Cherwinski, H. M., Jenmalm, M. C., Sedgwick, J. D., & Dick, A. D. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.070272 · Cited by 138
Burton, M. D., Sparkman, N. L., & Johnson, R. W. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-54 · Cited by 138
CD200 is induced by ERK and is a potential therapeutic target in melanoma
Petermann, K. B., Rozenberg, G. I., Zedek, D. C., Groben, P. A., McKinnon, K. P., Buehler, C., Kim, W. Y., Shields, J. M., Penland, S., Bear, J. E., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32163 · Cited by 130
Expression of the Inhibitory CD200 Receptor Is Associated with Alternative Macrophage Activation
Koning, N., van Eijk, M., Pouwels, W., Brouwer, M. S. M., Voehringer, D., Huitinga, I., Hoek, R. M., Raes, G., & Hamann, J. (2009) · Journal of Innate Immunity · doi:10.1159/000252803 · Cited by 130
Colton, C. A., Vitek, M. P., Wink, D. A., Xu, Q., Cantillana, V., Previti, M. L., Van Nostrand, W. E., Weinberg, J. B., & Dawson, H. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601075103 · Cited by 128
Spatial relationships between astrocytes and classical plaque components
Wisniewski, H. M., & Wegiel, J. (1991) · Neurobiology of Aging · doi:10.1016/0197-4580(91)90091-w · Cited by 124
Baer, R. M. (2003) · Cited by 122
The role of neuroimaging in mild cognitive impairment
Matsuda, H. (2007) · Neuropathology · doi:10.1111/j.1440-1789.2007.00794.x · Cited by 121
CD200: A putative therapeutic target in cancer
Moreaux, J., Veyrune, J. L., Reme, T. X., Vos, J. D., & Klein, B. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.11.103 · Cited by 118
Siva, A. C., Xin, H., Qin, F., Oltean, D. I., Bowdish, K. S., & Kretz-Rommel, A. (2007) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-007-0429-6 · Cited by 116
Tumor Necrosis Factor Alpha Inhibits Hepatocyte Mitochondrial Respiration
Stadler, J., Bentz, B. G., Harbrecht, B. G., Silvio, M. D., CURRAN, R. D., Billiar, T. R., HOFFMAN, R. A., & Simmons, R. L. (1992) · Annals of Surgery · doi:10.1097/00000658-199211000-00003 · Cited by 115
Reed-Geaghan, E. G., Reed, Q. W., Cramer, P. E., & Landreth, G. E. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.2637-10.2010 · Cited by 115
Localisation of the MRC OX‐2 Glycoprotein on the Surfaces of Neurones
Webb, M. H., & Barclay, A. N. (1984) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1984.tb12844.x · Cited by 114
Kiyota, T., Yamamoto, M., Xiong, H., Lambert, M. P., Klein, W. L., Gendelman, H. E., Ransohoff, R. M., & Ikezu, T. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006197 · Cited by 114
Self-citationInflammation, mitochondria, and the inhibition of adult neurogenesis
Voloboueva, L. A., & Giffard, R. G. (2011) · Journal of Neuroscience Research · doi:10.1002/jnr.22768 · Cited by 114
Behavior of neural stem cells in the Alzheimer brain
Waldau, B., & Shetty, A. K. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8053-y · Cited by 111
The participation of interleukin-6 in the pathogenesis of alzheimer's disease
Bauer, J., Ganter, U., Strauss, S., Stadtmüller, G., Frommberger, U., Bauer, H. C., Volk, B., & Berger, T. (1992) · Research in Immunology · doi:10.1016/0923-2494(92)80051-l · Cited by 110
DNA microarray analysis of the aging brain
Prolla, T. A. (2002) · Chemical Senses · doi:10.1093/chemse/27.3.299 · Cited by 110 · cited 1×
“…analyses of brain tissue from normally aging humans and mice showed significant up-regulation of certain genes that occurred with age, and about half of those genes were associated with inflammation and oxidative stress (Bishop et al. 2010; Loerch et al. 2008; Lu et al. 2004; Prolla 2002).”
BackgroundQin, H., Wilson, C. A., Roberts, K. L., Baker, B. J., Zhao, X., & Benveniste, E. N. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.11.7761 · Cited by 108
Lotz, M., Ebert, S., Esselmann, H., Iliev, A. I., Prinz, M., Wiazewicz, N., Wiltfang, J., Gerber, J., & Nau, R. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03188.x · Cited by 107
Tamura, Y., Kataoka, Y., Cui, Y., Takamori, Y., Watanabe, Y., & Yamada, H. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05617.x · Cited by 107
Cited by
Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?
Leng, F., & Edison, P. (2021) · Nature Reviews Neurology · doi:10.1038/s41582-020-00435-y · Cited by 3,179
Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes
Kwon, H. S., & Koh, S.-H. (2020) · Translational Neurodegeneration · doi:10.1186/s40035-020-00221-2 · Cited by 2,595
Microglial M1/M2 polarization and metabolic states
Orihuela, R., McPherson, C. A., & Harry, G. J. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13139 · Cited by 2,070
“In addition, within the normal CNS environment, microglia express high levels of microRNA-124, reducing expression of CD46, major histocompatibility complex-II (MHC-II) and CD11b serving to maintain the cells in a quiescent yet, surveillance state (Conrad and Dittel, 2011).”
BackgroundInfluentialNeuroinflammation in Alzheimer's disease: current evidence and future directions
Calsolaro, V., & Edison, P. (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.02.010 · Cited by 1,726
“demonstrated a distinctive shift from M2 to M1 phenotype of microglial activation [8].”
BackgroundInfluentialThe biphasic function of microglia in ischemic stroke
Ma, Y., Wang, J., Wang, Y., & Yang, G.-Y. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.01.005 · Cited by 655
Metadata
- Authors
- Varnum, M. M., & Ikezu, T.
- Venue
- Archivum Immunologiae et Therapiae Experimentalis
- Publisher
- Walter de Gruyter GmbH
- Published
- 2012-06-19
- Volume
- 60
- Issue
- 4
- Pages
- 251-266
- ISSN
- 0004-069X (ISSN-L)
- 1661-4917
- OpenAlex
- W2122000781
- Cited by
- 394
- References
- 228
- FWCI
- 13.51
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.